NEXGEN ENERGY LTD (NXE) Fundamental Analysis & Valuation

NYSE:NXE • CA65340P1062

Current stock price

10.69 USD
-0.35 (-3.17%)
Last:

This NXE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. NXE Profitability Analysis

1.1 Basic Checks

  • In the past year NXE has reported negative net income.
  • NXE had a negative operating cash flow in the past year.
  • In the past 5 years NXE reported 4 times negative net income.
  • In the past 5 years NXE always reported negative operating cash flow.
NXE Yearly Net Income VS EBIT VS OCF VS FCFNXE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M

1.2 Ratios

  • The Return On Assets of NXE (-12.52%) is worse than 84.21% of its industry peers.
  • Looking at the Return On Equity, with a value of -16.90%, NXE is doing worse than 76.08% of the companies in the same industry.
Industry RankSector Rank
ROA -12.52%
ROE -16.9%
ROIC N/A
ROA(3y)-3.06%
ROA(5y)-8.23%
ROE(3y)-4.54%
ROE(5y)-10.93%
ROIC(3y)N/A
ROIC(5y)N/A
NXE Yearly ROA, ROE, ROICNXE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80 -100

1.3 Margins

  • NXE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NXE Yearly Profit, Operating, Gross MarginsNXE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

7

2. NXE Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, NXE has more shares outstanding
  • NXE has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, NXE has an improved debt to assets ratio.
NXE Yearly Shares OutstandingNXE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
NXE Yearly Total Debt VS Total AssetsNXE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 8.55 indicates that NXE is not in any danger for bankruptcy at the moment.
  • NXE has a better Altman-Z score (8.55) than 92.34% of its industry peers.
  • There is no outstanding debt for NXE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 8.55
ROIC/WACCN/A
WACCN/A
NXE Yearly LT Debt VS Equity VS FCFNXE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • NXE has a Current Ratio of 1.82. This is a normal value and indicates that NXE is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of NXE (1.82) is better than 71.77% of its industry peers.
  • NXE has a Quick Ratio of 1.82. This is a normal value and indicates that NXE is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 1.82, NXE is doing good in the industry, outperforming 74.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.82
NXE Yearly Current Assets VS Current LiabilitesNXE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1

3. NXE Growth Analysis

3.1 Past

  • NXE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -81.43%.
EPS 1Y (TTM)-81.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.45%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 26.73% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y57.85%
EPS Next 2Y18.89%
EPS Next 3Y10.22%
EPS Next 5Y26.73%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NXE Yearly Revenue VS EstimatesNXE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2024 2029 2030 2031 2032 2033 1B 2B 3B
NXE Yearly EPS VS EstimatesNXE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4

0

4. NXE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NXE. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NXE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXE Price Earnings VS Forward Price EarningsNXE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXE Per share dataNXE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.89%
EPS Next 3Y10.22%

0

5. NXE Dividend Analysis

5.1 Amount

  • NXE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

NXE Fundamentals: All Metrics, Ratios and Statistics

NEXGEN ENERGY LTD

NYSE:NXE (3/30/2026, 3:17:09 PM)

10.69

-0.35 (-3.17%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)03-03
Earnings (Next)05-11
Inst Owners58.78%
Inst Owner Change8.44%
Ins Owners2.09%
Ins Owner ChangeN/A
Market Cap6.50B
Revenue(TTM)N/A
Net Income(TTM)-309.68M
Analysts80
Price Target13.24 (23.85%)
Short Float %13.39%
Short Ratio8.42
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-330.96%
Min EPS beat(2)-570.22%
Max EPS beat(2)-91.7%
EPS beat(4)1
Avg EPS beat(4)-179.13%
Min EPS beat(4)-570.22%
Max EPS beat(4)241.44%
EPS beat(8)3
Avg EPS beat(8)-103.66%
EPS beat(12)4
Avg EPS beat(12)-110.15%
EPS beat(16)4
Avg EPS beat(16)-175.2%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)13.8%
EPS NQ rev (1m)-11.11%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)2.45%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.92
P/tB 4.92
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0
BVpS2.17
TBVpS2.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -12.52%
ROE -16.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-3.06%
ROA(5y)-8.23%
ROE(3y)-4.54%
ROE(5y)-10.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 8436.32%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.82
Altman-Z 8.55
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)6886.25%
Cap/Depr(5y)5323.39%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-81.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.45%
EPS Next Y57.85%
EPS Next 2Y18.89%
EPS Next 3Y10.22%
EPS Next 5Y26.73%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year50.3%
EBIT Next 3Y10.82%
EBIT Next 5Y46.64%
FCF growth 1Y-50.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-97.25%
OCF growth 3YN/A
OCF growth 5YN/A

NEXGEN ENERGY LTD / NXE Fundamental Analysis FAQ

What is the fundamental rating for NXE stock?

ChartMill assigns a fundamental rating of 2 / 10 to NXE.


What is the valuation status for NXE stock?

ChartMill assigns a valuation rating of 0 / 10 to NEXGEN ENERGY LTD (NXE). This can be considered as Overvalued.


Can you provide the profitability details for NEXGEN ENERGY LTD?

NEXGEN ENERGY LTD (NXE) has a profitability rating of 0 / 10.


Can you provide the financial health for NXE stock?

The financial health rating of NEXGEN ENERGY LTD (NXE) is 7 / 10.